Liver Cancer Therapeutics Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 January 24
SKU : PH3412
excelpdfpowerpoint
180 pages
Report Summary
Table of Contents
List of Tables & Figures
loading
Buy this report
Single User
$4350
Multiple User
$4850
Enterprise User
$7850
Proceed to Buy
Request new version
FAQ’s
What is the Projected CAGR value of the Liver Cancer Therapeutics Market?
The liver Cancer Therapeutics Market is expected to grow at a CAGR of 11.70% during the forecast period 2024-2031.
Who are the Key players contributing to the market's growth?
The Key Players are Amgen Inc, AstraZeneca PLC, Bayer AG, Celgene Corporation, Eli Lilly, Bristol-Myers Squibb Company, Gilead Sciences, Inc., Takeda Pharmaceutical Company Limited, Daiichi Sankyo Company, Limited and UCB SA.
Related Reports
pharmaceuticals

Europe Theranostics Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2023 October 27
Starting from

$3750

pharmaceuticals

Europe Ovarian Cancer Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2023 September 25
Starting from

$3750

pharmaceuticals

Europe Liver Cancer Therapeutics Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2023 September 25
Starting from

$3750

pharmaceuticals

Salivary Gland Cancer Treatment Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2023 October 04
Starting from

$4350

pharmaceuticals

Malignant Mesothelioma Therapeutics Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2023 June 07
Starting from

$4350

pharmaceuticals

Oncolytic Virotherapy Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2024 January 02
Starting from

$4350